Status:
COMPLETED
Letrozole or Laparoscopic Ovarian Diathermy for Women With CC Resistant Polycystic Ovary Syndrome.
Lead Sponsor:
Mansoura University
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
20-36 years
Phase:
NA
Brief Summary
The purpose of this study is to compare and determine the efficacy of letrozole administration to that of laparoscopic ovarian diathermy (LOD) in infertile women with Polycystic ovary syndrome(PCOS)no...
Detailed Description
In the letrozole group, withdrawal bleeding was achieved using 10 mg of dydrogesterone tablets for 10 days before stimulation, then 2.5 mg of letrozole oral tablets (Femara; Novartis Pharma Services, ...
Eligibility Criteria
Inclusion
- CC resistant PCOS
Exclusion
- Congenital adrenal hyperplasia
- Cushing syndrome
- Androgen secreting tumors
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
260 Patients enrolled
Trial Details
Trial ID
NCT00956267
Start Date
August 1 2006
End Date
March 1 2009
Last Update
August 11 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura University Hospitals,OB/GYN department
Al Mansurah, Dakahlia Governorate, Egypt, 35511